Icon
+91 94997 68112
Login Register

Isentress - (400 mg; Tablet)

Raltegravir Potassium Merck
400 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
None None
ISENTRESS™ is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
Yes
***** ** *** *** *** ********* *** *** ******* ** *** ******* **** *******. ** *** ****, ***** **** ****** **** ************ ** ****** '***. ********* ** *****'* *** ******, ***** ****** *** ********* ******* ** **** ** *** **.
Isentress Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
****** *** ********* *** ********* *** ********* ******* ***** ******** ************ *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ *** -**- ******* ******** ************ ******* *** **** *** **** ****
  1. *** **, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** *, **** : ****** ******** ***** ** ***** **** ** ******.
  3. *** **, **** : ****** ******** ********* ******** **** *** *** *** *** *********
  4. *** **, **** : ***** **** ****** **** ************ ** ****** '***.
  5. *** **, **** : ***** *** ****** **** ******* ********** **** ******* *****. ****** ****** ********** ****** **. '***.

Isentress - (25MG, 100MG)

Raltegravir Potassium None
25MG, 100MG
Less Than $1000 mn
None None
None None
None None
Adult Patients: ISENTRESS and ISENTRESS HD are human immunodeficiency virus integrase strand transfer inhibitors (HIV-1 INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients. Pediatric Patients: ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 2 kg.
Yes
Isentress Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Isentress - (100MG)

Raltegravir Potassium None
100MG
Less Than $1000 mn
None None
None None
None None
Adult Patients: ISENTRESS and ISENTRESS HD are human immunodeficiency virus integrase strand transfer inhibitors (HIV-1 INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients. Pediatric Patients: ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 2 kg.
Yes
Isentress Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.